Mod 3 Asthma Flashcards
what do COPD and Asthma have in common?
Airflow limitations (Air trapping) and dynamic breathing
What are usual characteristic of asthma according to global initiative for asthma [gina]?
Chronic airway inflammation w/symptoms of:
-wheeze
-SOB
- chest tightness
-cough
-variable expiratory flow limitations (Big diff from COPD)
Generally describe an asthma episode
Extreme bronchoconstriction on inhalation and expiration
Why is it essential to pair a corticosteroid w/SABD for a asthma attack?
Bronchodilators open up the airways but do nothing to treat the underlying inflammation.
Assessing risk for severe exacerbation
History of severe asthma exacerbations; ED visit
Poorly asthma controlled asthma per CTS critera
Overuse of SABAs i.e > 2 a year (or no ICS use)
current smoker
What is the most effective controller for asthma?
What is the time frame of affect?
ICS
Improvement occurs within 1-2 weeks of starting daily use.
suppression of Asthma; what are the most affective controllers of asthma?
edit
Slide 17
ICS
Suppression of:
-inflammatory genes i.e cytokines and eosinophils
Are ICS affective for smokers
Nope.
Smoke generates oxidative stress that impairs activity of ICS.
Describe the ICS and B2 adrenergic receptors relationship
ICS can activate B2 receptors; enhancing B2 agonist effects
ICS can also prevent the down regulation of B2 receptors (increasing expression of them on the cell surface)
systemic corticosteroids vs. inhaled corticosteroids?
edit
need to check for accuracy
One is broader vs. the lungs itself
Inhaled have the same affect for asthma as systemic but w/o the issues that come with systemic use
GINA vs CTS
CTS; SABA only
GINA; subbing in budesonide/formatarol as a relievers (LABA w/a shorter onset (oxeze)
2021 asthma management pathway
- Confirm diagnosis
- environmental control, education, action plan
- SABA or budesonide/formeterol
- ICS -> followed by LTRA
- LABA
- LTRA or LABA
budesonide can be used for what?
A reliever and controller
Reliever meds for asthma
salbutamol, terbutaline, and budesonide/formoterol
What does regular use of a reliever looked like?
and why is it important
More than 2 doses per week.
identifies evaluation of use of and effectiveness
Risk factors of improper SABA use?
SABAs can increase risk of exaserbation
-not controlling the inflammation enough
-should be using a ICS more effecitly in conjunction w/saba
What do you do when a patient can’t tolerate ICS?
Switch to a LTRA
slide 27 won’t be tested. but the second line on gina is the general rule of thumb that we follow
don’t worry about slide 30
understand CTS step approach to treatment
How often should asthma be reviewed for the following scenarios:
- After diagnosis
- During Pregancy
- After an exacerbation
1. [1-3] months after treatment started, then every [3-12] months
2. During pregnancy: Every [4-6] weeks
3. After an exacerbation: within 1 week
3 strategies to manage asthma
Education
Environmental control; i.e allergies
pharmacotherapy
What is used to treat an anaphylactic reactions? (allergy based)
Epinephrine
w/asthma can produce a severe anaphylactic reaction
Asthma risk factors: How would a prenatal population get asthma?
Heredity
Maternal factors:
-smoking during pregnancy
-Low vit. D during pregnancy
-Cesarean delivery
Asthma risk factors: How would children get asthma?
-Eczema
-Allergic rhinitis
- Exposure to second hand smoke
-Air pollution
-Obesity
Asthma risk factors: for infancy, preschool, school, age etc.?
exposure to allergens (antigen)
i.e fungi, dust, etc.
Asthma risk factors for adulthood
Exposure to allergens
pollution/ Tobacco smoke/occupational exposure
drugs/additives
diet/obesity
Gender
What are some symptoms usually associated w/asthma?
Wheeze
SOB
Chest tightness
Cough
Asthma is primarily characterized by
variable expiratory airflow limitation
Symptoms of airflow limitation vary overtime and intensity; what factors can trigger incidents?
Exercise
Allergen/irritant exposure
Changes to weather
Viral resp. infections
How long can asthma symptoms be absent for?
Weeks or months at a time.
List some Asthma phenotypes
-Allergic asthma
-non-allergic asthma
-adult-onset (late-onset) asthma
-Occupational asthma
-Asthma w/obesity
-Asthma w/persistent airflow limitation
Define common traits of Allergic asthma:
- History
- Sputum profile
- Best Treatment Plan
Associated w/past or fam. allergic disease
-i.e eczema
Sputum profile: Treatment reveals eosinophilic airway inflammation
Usually responds well to ICS
Sputum profile/Traits of non-allergic asthma?
- response to treatments?
Sputum profile: may be neutrophilic, eosinophilia, or contain a few inflammatory cells
Demonstrates less short term response to ICS
Traits of adult-onset (late-onset) asthma
Effects women > Men
-tend to be non-allergic
Require higher doses of ICS, relatively refractory to ICS treatment.
Define occupational asthma
repeat exposure to a sensitized in the workplace or asthma worsens in the workplace
i.e dusts, plants, animal substances
How is occupational asthma checked?
Patient history;
—ask if symptoms improve away from work
Peak expiratory flows
Define asthma w/persistent airflow limitation
Due to airway remodeling
-develop airflow limitation that is persistent or incompletely irreversible
Traits of Asthma w/obesity
Prominent respiratory symptoms and little eosinophilia airway inflammation
Anatomic alterations of the lungs;
what traits would be present/affected by Asthma inflamed bronchial tubes
Increased eosinophils
excessive secretions
hyperinflation
bronchospasm
Bronchial inflammation
Anatomic alterations of the lungs; Bronchial inflammation
Inflammation throughout the submucosa of airways; but not the alveoli/lung parenchyma.
Describe Primary and stimulated eosinophils during bronchial inflammation
edit
Slide 23
CTS Typical Severity Classification: Very mild
AKA well controlled
PRN SABA
CTS Typical Severity Classification: mild
Low dose ICS (or LTRA -> Montelukast)
+
PRN SABA or PRN bud/form [Symbicort]
CTS Typical Severity Classification: Moderate + well controlled
Low dose ICS
+
Second controller (LABA) and PRN SABA
CTS Typical Severity Classification: Moderate w/increasing severity
Moderate dose ICS +/- second controller
AND
PRN SABA or PRN low-mod. dose of Symbicort
CTS Typical Severity Classification: HIGH
High dose ICS + second controller
For previous year or systemic steroids for 50% of the previous year to prevent asthma from being uncontrolled to prevent asthma from being uncontrolled, or is uncontrollable despite this therapy.